Diagnostics of Coronavirus Disease 2019 Cardiovascular Complications

Launched by I.M. SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY · Nov 5, 2022

Keywords

ClinConnect Summary

Aim of this prospective, observational, multi-centered, randomized study is to detect cardiovascular complications in patients after coronavirus infection.

The study will include 100 patients who underwent confirmed by laboratory tests Coronavirus Disease 2019 (COVID-19) infection (polymerase chain reaction (PCR) testing, enzyme-linked immunosorbent assay (positive result at least 1 time)) 1-3 months ago with the degree of lung lesion more than 25%, who were admitted to the University Clinical Hospital No. 4 of I.M. Sechenov First Moscow State Medical University.

The study consists of 4 p...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Written informed consent to participate in the study;
• • 2. Age 18 and over;
• • 3. Male and female;
• • 4. COVID-19 infection confirmed by laboratory tests (polymerase chain reaction testing, enzyme-linked immunosorbent assay (positive result at least 1 time) with a CT degree more that 25% of lung lesion.
• • 5. No more than 3 months after discharge from infectious department
• Non-inclusion criteria:
• • 1. Unable to sign informed consent;
• • 2. Mental illness (severe dementia, schizophrenia, severe depression, manic-depressive psychosis);
• • 3. Acute coronary syndrome, acute cerebrovascular accident, pulmonary embolism within the last 3 months;
• • 4. Oncology;
• • 5. Diseases and conditions that can change the ECG picture and complicate the analysis of the ECG (conduction disturbance, pacemaker);
• • 6. Inability to use a heart monitor (congenital developmental anomalies, traumatic amputation of the upper limbs, essential tremor, Parkinson's disease);
• • 7. Severe comorbidities with life expectancy less than 1 year.
• Exclusion Criteria:
• • 1. Refusal to further participation in the study;
• • 2. Acute infectious diseases, tuberculosis
• • 3. Oncology arising in the process of the study
• • 4. Acute coronary syndrome, acute cerebrovascular accident, pulmonary embolism arising in the process of the study
• • 5. Acute psychotic reactions arising in the process of the study;
• • 6. Inability to use a heart monitor arising in the process of the study